Dewan Zeng, MBA;PhD

Reno, Nevada, United States
In her 24 years in the pharmaceutical industry, Dewan has played critical roles in advancing global clinical development programs and establishing strategic partnerships between pharmaceutical and biotech companies. Currently, Dewan is Vice President, Head of Search and Evaluation, Business Development at BeiGene. She leads a global team of professionals in the US, Europe and China to evaluate innovative products and technologies to strengthen BeiGene’s portfolio.
Prior to joining BeiGene, Dewan led global development teams at Pfizer, Gilead and CV Therapeutics. She led programs from IND to NDA and supported the approval and launch of three pharmaceutical products in the US, Europe and China. Dewan has a Bachelor's degree in Biochemistry from Peking University, a PhD in Biochemistry from University of Virginia, and an MBA in Global Business Strategy from Cal State University East Bay. She completed her post-doctoral training at UCSF. She has over 50 publications in peer-reviewed journals and is the inventor of 8 issued patents in the US and globally.
Speaking In
3:30 PM - 5:00 PM (PDT)
Monday, June 13
Learn the latest about biomedical innovation within the China biotech community from this showcase…